ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023
Emerging Enhancement and Regulation Strategies for Ferromagnetic 2D Transition Metal Dichalcogenides.
Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Two-dimensional WRSC advances · 2026Article
- Oxygen Plasma-Induced Magnetic Modulation and Air Stability Enhancement of 2D 1T-CrTeSmall (Weinheim an der Bergstrasse, Germany) · 2026Article
- Defects That Magnetize Beyond Monolayer PtSeSmall (Weinheim an der Bergstrasse, Germany) · 2026Article
- Coverage-Dependent Structural Evolution of CoBrAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Electronic and Magnetic Properties of Manganese Bromide Monolayers.Langmuir : the ACS journal of surfaces and colloids · 2025Article
- Transition Metal Dichalcogenides: Making Atomic-Level Magnetism Tunable with Light at Room Temperature.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024Article
- Defect engineered magnetism induction and electronic structure modulation in monolayer MoSHeliyon · 2024Article
- Emerging Enhancement and Regulation Strategies for Ferromagnetic 2D Transition Metal Dichalcogenides.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Two-dimensional transition metal dichalcogenides (2D TMDs) present promising applications in various fields such as electronics, optoelectronics, memory devices, batteries, superconductors, and hydrogen evolution reactions due to their regulable energy band structures and unique properties. For emerging spintronics applications, materials with excellent room-temperature ferromagnetism are required. Although most transition metal compounds do not possess room-temperature ferromagnetism on their own, they are widely modified by researchers using the emerging strategies to engineer or modulate their intrinsic properties. This paper reviews recent enhancement approaches to induce magnetism in 2D TMDs, mainly using doping, vacancy defects, composite of heterostructures, phase modulation, and adsorption, and also by electron irradiation induction, O plasma treatment, etc. On this basis, the produced effects of these methods for the introduction of magnetism into 2D TMDs are compressively summarized and constructively discussed. For perspective, research on magnetic doping techniques for 2D TMDs materials should be directed toward more reliable and efficient directions, such as exploring advanced design strategies to combine dilute magnetic semiconductors, antiferromagnetic semiconductors, and superconductors to develop new types of heterojunctions; and advancing experimentation strategies to fabricate the designed materials and enable their functionalities with simultaneously pursuing the upscalable growth methods for high-quality monolayers to multilayers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.